kamuhealth.com

What It Is

KAMU Health’s KAMU Asthma is a digital health solution for people with respiratory conditions. It combines a clinical-grade mobile spirometer with a smartphone app to help users monitor lung health, medication use, and symptoms. It is closer to a healthcare SaaS / software-hardware hybrid product than general-purpose enterprise software.

Core Features and Collaboration

The product centers on lung function monitoring, symptom and medication logging, plus local weather and air quality forecasts. For patients with asthma and other respiratory diseases, environmental factors are closely linked to symptom changes, so incorporating air quality and weather into the app has practical value. The available description also states that users can see whether their lung condition is worsening and take action accordingly. In terms of data, users can share data from their phones with healthcare professionals and researchers after granting permission. However, there is no further disclosure about a clinician dashboard, team collaboration, role-based permissions, or institutional management capabilities.

Pricing, Security, and Integrations

The current public description does not provide information on plans, pricing, payment methods, a free version, or trials. It also does not state whether it supports insurance coverage, healthcare-institution procurement, or out-of-pocket patient purchases. On security and compliance, the only confirmed point is that data sharing requires user authorization; details on privacy policies, data encryption, medical device certification, HIPAA/GDPR compliance, and related matters are not disclosed. There is also no information on third-party integrations, electronic health record connectivity, APIs, or developer support.

Pros and Cons

Its strengths are a focused use case and the ability to combine clinical-grade measurement hardware, a mobile app, medication and symptom logs, and environmental forecasts in one solution. It can also provide authorized data to doctors and researchers. Potential drawbacks include limited public information, especially around pricing, compliance, data security, deployment options, and healthcare-organization features, making it insufficiently transparent for enterprise procurement evaluation.

Who It’s For and Access from China

It is suitable for asthma patients or people with other respiratory conditions who need at-home lung function monitoring. It may also be useful for healthcare professionals and researchers who want access to long-term patient lung data. Availability from China is unknown; support for Chinese language, local payments, domestic compliance, and hardware shipping has not been disclosed. If deployed in China, it would typically also need to address local medical device registration, data compliance, and hospital system integration.